Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Thalassemia
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
Related Questions
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
Can lupus anticoagulant be positive despite a normal aPTT?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
What hemoglobin level do you target for adult beta thalassemia intermedia patients with a pre-transfusion Hb >7 g/dl?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How quickly do you expect iron stores to decrease after starting iron chelators?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
